DE69535125D1 - Impstoff gegen felines immunodefizienz-virus - Google Patents
Impstoff gegen felines immunodefizienz-virusInfo
- Publication number
- DE69535125D1 DE69535125D1 DE69535125T DE69535125T DE69535125D1 DE 69535125 D1 DE69535125 D1 DE 69535125D1 DE 69535125 T DE69535125 T DE 69535125T DE 69535125 T DE69535125 T DE 69535125T DE 69535125 D1 DE69535125 D1 DE 69535125D1
- Authority
- DE
- Germany
- Prior art keywords
- gag
- mucosal
- parenteral
- fiv
- env
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000282324 Felis Species 0.000 title 1
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- DYAHQFWOVKZOOW-UHFFFAOYSA-N Sarin Chemical compound CC(C)OP(C)(F)=O DYAHQFWOVKZOOW-UHFFFAOYSA-N 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 101710177291 Gag polyprotein Proteins 0.000 abstract 4
- 101710125418 Major capsid protein Proteins 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 102100034353 Integrase Human genes 0.000 abstract 2
- 108010078428 env Gene Products Proteins 0.000 abstract 2
- 241000701087 Felid alphaherpesvirus 1 Species 0.000 abstract 1
- 238000011081 inoculation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 241000701447 unidentified baculovirus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23642994A | 1994-04-29 | 1994-04-29 | |
US236429 | 1994-04-29 | ||
PCT/US1995/003998 WO1995030019A1 (en) | 1994-04-29 | 1995-04-05 | Feline immunodeficiency virus vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69535125D1 true DE69535125D1 (de) | 2006-09-07 |
DE69535125T2 DE69535125T2 (de) | 2007-08-30 |
Family
ID=22889471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69535125T Expired - Fee Related DE69535125T2 (de) | 1994-04-29 | 1995-04-05 | Impfstoff gegen felines immunodefizienz-virus |
Country Status (8)
Country | Link |
---|---|
US (1) | US5833993A (de) |
EP (2) | EP0758396B1 (de) |
JP (1) | JPH09512177A (de) |
AT (1) | ATE334216T1 (de) |
AU (1) | AU2234995A (de) |
DE (1) | DE69535125T2 (de) |
ES (1) | ES2267101T3 (de) |
WO (1) | WO1995030019A1 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6348449B1 (en) | 1993-09-21 | 2002-02-19 | The Trustees Of The University Of Pennsylvania | Methods of inducing mucosal immunity |
FR2732605B1 (fr) * | 1995-04-07 | 1997-05-16 | Pasteur Merieux Serums Vacc | Composition destinee a l'induction d'une reponse immunitaire mucosale |
US5849303A (en) * | 1995-06-07 | 1998-12-15 | American Home Products Corporation | Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection |
US6254872B1 (en) * | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
FR2741806B1 (fr) * | 1995-11-30 | 1998-02-20 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline |
FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
JP2001500738A (ja) * | 1996-09-17 | 2001-01-23 | カイロン コーポレイション | 細胞内疾患を処置するための組成物および方法 |
US7255862B1 (en) | 1996-11-14 | 2007-08-14 | Connaught Technology Corporation | ALVAC/FIV constructs |
US20030118601A1 (en) * | 1997-03-11 | 2003-06-26 | Neil James Charles | FIV vaccine |
US6458528B1 (en) * | 1998-05-15 | 2002-10-01 | Idexx Laboratories, Inc. | Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers |
WO2000024428A2 (en) * | 1998-10-23 | 2000-05-04 | Heska Corporation | Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
US6770282B1 (en) | 1998-10-23 | 2004-08-03 | Heska Corporation | Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
US20030198661A1 (en) * | 2000-01-31 | 2003-10-23 | Mars Incorporated | Antioxidant compositions and methods for companion animals |
EP1074625A3 (de) * | 1999-06-14 | 2002-01-02 | Pfizer Products Inc. | DNS impfstoff gegen das immunschwächevirus der Katze |
WO2001004280A2 (de) * | 1999-07-08 | 2001-01-18 | Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze |
FR2825280B1 (fr) * | 2001-06-01 | 2005-04-15 | Merial Sas | Vaccination contre le virus de l'immunodeficience feline |
WO2006011919A1 (en) * | 2004-06-30 | 2006-02-02 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
ATE435425T1 (de) * | 2003-09-11 | 2009-07-15 | Idexx Lab Inc | Verfahren zum nachweis des felinen immunschwächevirus |
AU2004304348B2 (en) * | 2003-12-18 | 2009-02-26 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
WO2005080939A2 (en) * | 2004-02-19 | 2005-09-01 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
AU2005267605B2 (en) * | 2004-06-30 | 2009-03-26 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
WO2006011920A1 (en) * | 2004-06-30 | 2006-02-02 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein |
US7291338B2 (en) * | 2005-03-09 | 2007-11-06 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
US20120040367A1 (en) * | 2007-10-15 | 2012-02-16 | The University Of Queensland | Construct system and uses therefor |
US20100291142A1 (en) * | 2007-10-18 | 2010-11-18 | Roger Maes | Bacterial Artificial Chromosome Containing Feline Herpes Virus Type 1 Genome and Uses Thereof |
WO2011123781A1 (en) | 2010-04-02 | 2011-10-06 | Idexx Laboratories, Inc. | Detection of feline immunodeficiency virus |
US9795658B2 (en) | 2010-04-20 | 2017-10-24 | Admedus Vaccines Pty Ltd | Expression system for modulating an immune response |
LT3333265T (lt) | 2010-05-14 | 2020-05-25 | Oregon Health & Science University | Rekombinantiniai žcmv ir rhcmv vektoriai, koduojantys heterologinį antigeną, išskirtą iš hepatito b viruso, ir jų panaudojimas |
PL2691530T3 (pl) | 2011-06-10 | 2019-02-28 | Oregon Health & Science University | Glikoproteiny i rekombinowane wektory CMV |
JP6483033B2 (ja) * | 2013-03-05 | 2019-03-13 | オレゴン・ヘルス・アンド・サイエンス・ユニバーシティOregon Health & Science University | T細胞ターゲティングを調節することができるサイトメガロウイルスベクター |
CN107002048B (zh) | 2014-07-16 | 2021-07-06 | 俄勒冈健康与科学大学 | 包含外源抗原的人巨细胞病毒 |
EP3256595A4 (de) | 2015-02-10 | 2018-09-26 | Oregon Health & Science University | Verfahren und zusammensetzungen zur erzeugung nicht kanonischer cd8+t-zellantworten |
MA43285A (fr) | 2015-11-20 | 2018-09-26 | Univ Oregon Health & Science | Vecteurs cmv comprenant des éléments de reconnaissance des microarn |
WO2017096432A1 (en) | 2015-12-09 | 2017-06-15 | Admedus Vaccines Pty Ltd | Immunomodulating composition for treatment |
MX2019004518A (es) | 2016-10-18 | 2019-06-17 | Univ Oregon Health & Science | Vectores de citomegalovirus que provocan celulas t restringidas por moleculas del complejo mayor de histocompatibilidad e. |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5118602A (en) * | 1987-08-26 | 1992-06-02 | The Regents Of The University Of California | Feline T-lymphotropic lentivirus assay |
CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
US5324664A (en) * | 1988-08-08 | 1994-06-28 | The Upjohn Company | Herpes virus thymidien kinase-encoding DNA |
JP3058685B2 (ja) * | 1989-05-08 | 2000-07-04 | アイデックス ラボラトリーズ インコーポレーテッド | ネコt細胞リンパトロピック レンチウィルスのポリペプチド |
AU5848390A (en) * | 1989-06-01 | 1991-01-07 | Applied Biotechnology, Inc. | Self-assembled, defective, non-self-propagating viral particles |
US6228608B1 (en) * | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
EP0613378A1 (de) * | 1991-10-28 | 1994-09-07 | Institut Pasteur | Induzierung von schützen gegen virale infektionen durch die synergie zwischen virale proteine und virale peptide |
DK0576092T3 (da) * | 1992-06-26 | 2003-02-17 | Akzo Nobel Nv | Rekombineret felin herbesvirusvaccine |
GB9215233D0 (en) * | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
GB9215232D0 (en) * | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
DE69332480T2 (de) * | 1992-07-30 | 2003-07-17 | Akzo Nobel Nv | Impfstoff-vektoren von rekombinantem katzen-herpesvirus |
GB9219936D0 (en) * | 1992-09-21 | 1992-11-04 | Pitman Moore Inc | Vaccines |
JPH08501452A (ja) * | 1992-09-21 | 1996-02-20 | ビアジーン,インコーポレイティド | Felv及び/又はfivに対する組換レトロウィルスベクター |
-
1995
- 1995-04-05 WO PCT/US1995/003998 patent/WO1995030019A1/en active IP Right Grant
- 1995-04-05 EP EP95915480A patent/EP0758396B1/de not_active Expired - Lifetime
- 1995-04-05 DE DE69535125T patent/DE69535125T2/de not_active Expired - Fee Related
- 1995-04-05 ES ES95915480T patent/ES2267101T3/es not_active Expired - Lifetime
- 1995-04-05 AT AT95915480T patent/ATE334216T1/de not_active IP Right Cessation
- 1995-04-05 JP JP7528228A patent/JPH09512177A/ja not_active Ceased
- 1995-04-05 AU AU22349/95A patent/AU2234995A/en not_active Abandoned
- 1995-04-05 EP EP06101626A patent/EP1679377A1/de not_active Withdrawn
- 1995-04-05 US US08/732,245 patent/US5833993A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2267101T3 (es) | 2007-03-01 |
EP0758396A1 (de) | 1997-02-19 |
EP1679377A1 (de) | 2006-07-12 |
WO1995030019A1 (en) | 1995-11-09 |
ATE334216T1 (de) | 2006-08-15 |
US5833993A (en) | 1998-11-10 |
DE69535125T2 (de) | 2007-08-30 |
JPH09512177A (ja) | 1997-12-09 |
AU2234995A (en) | 1995-11-29 |
EP0758396B1 (de) | 2006-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69535125D1 (de) | Impstoff gegen felines immunodefizienz-virus | |
BR9611845A (pt) | Vacina viva recombinante à base de herpesvírus felino de tipo 1 notadamente contra a peritonite infecciosa felina | |
NZ331161A (en) | Synthetic HIV genes encoding envelope (env) proteins | |
GR3030811T3 (en) | Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof | |
DK0969862T3 (da) | Syntetisk HIV gag-gener | |
DE69534778D1 (en) | Cathepsin-02-protease | |
DE68929467D1 (de) | HIV-2 Varianten | |
TW377373B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease | |
DK0484382T3 (da) | Felint calicivirus-capsid-protein og nucleotidsekvens | |
EA199900893A1 (ru) | Бактериальные плазмиды | |
ZA941853B (en) | Stimulation of immune response by viral protein | |
AU2003281917A8 (en) | Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats | |
WO1998042847A3 (de) | Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung | |
Wardley et al. | Feline immunodeficiency virus vaccine | |
IT1286307B1 (it) | Virus mixomatoso ricombinante, suo impiego per la produzione di un vaccino e relativo vaccino. | |
EE200100234A (et) | PRV-1-geen ja selle kasutamine | |
ATE236979T1 (de) | Leishmania hauptprotein, dafür kodierende nukleinsaüre und verwendungen davon | |
EP0816507A4 (de) | Neues rekombinantes gen | |
DE60135971D1 (de) | Mit wt1 interagierendes protein, wtip | |
EA199900726A1 (ru) | Синтетические hiv gag гены | |
ITVI940084A0 (it) | Impilatore per prodotti laminari flessibili, particolarmente per pellied affini. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |